Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk
The objective of this study was to determine whether multi-microRNA analysis using a combination of four microRNA biomarkers (miR-1246, 202, 21, and 219B) could improve the diagnostic performance of mammography in determining breast cancer risk by age group (under 50 vs. over 50) and distinguish bre...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | The Breast Journal |
| Online Access: | http://dx.doi.org/10.1155/2023/9117047 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849467863249715200 |
|---|---|
| author | Ji-Eun Song Ji Young Jang Kyung Nam Kang Ji Soo Jung Chul Woo Kim Ah Sol Kim |
| author_facet | Ji-Eun Song Ji Young Jang Kyung Nam Kang Ji Soo Jung Chul Woo Kim Ah Sol Kim |
| author_sort | Ji-Eun Song |
| collection | DOAJ |
| description | The objective of this study was to determine whether multi-microRNA analysis using a combination of four microRNA biomarkers (miR-1246, 202, 21, and 219B) could improve the diagnostic performance of mammography in determining breast cancer risk by age group (under 50 vs. over 50) and distinguish breast cancer from benign breast diseases and other cancers (thyroid, colon, stomach, lung, liver, and cervix cancers). To verify breast cancer classification performance of the four miRNA biomarkers and whether the model providing breast cancer risk score could distinguish between benign breast disease and other cancers, the model was verified using nonlinear support vector machine (SVM) and generalized linear model (GLM) and age and four miRNA qRT-PCR analysis values (dCt) were input to these models. Breast cancer risk scores for each Breast Imaging-Reporting and Data System (BI-RADS) category in multi-microRNA analysis were analyzed to examine the correlation between breast cancer risk scores and mammography categories. We generated two models using two classification algorithms, SVM and GLM, with a combination of four miRNA biomarkers showing high performance and sensitivities of 84.5% and 82.1%, a specificity of 85%, and areas under the curve (AUCs) of 0.967 and 0.965, respectively, which showed consistent performance across all stages of breast cancer and patient ages. The results of this study showed that this multi-microRNA analysis using the four miRNA biomarkers was effective in classifying breast cancer in patients under the age of 50, which is challenging to accurately diagnose. In addition, breast cancer and benign breast diseases can be classified, showing the possibility of helping with diagnosis by mammography. Verification of the performance of the four miRNA biomarkers confirmed that multi-microRNA analysis could be used as a new breast cancer screening aid to improve the accuracy of mammography. However, many factors must be considered for clinical use. Further validation with an appropriate screening population in large clinical trials is required. This trial is registered with (KNUCH 2022-04-036). |
| format | Article |
| id | doaj-art-e0fd87c722f04924bd4d57b27aac58ec |
| institution | Kabale University |
| issn | 1524-4741 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Breast Journal |
| spelling | doaj-art-e0fd87c722f04924bd4d57b27aac58ec2025-08-20T03:26:00ZengWileyThe Breast Journal1524-47412023-01-01202310.1155/2023/9117047Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer RiskJi-Eun Song0Ji Young Jang1Kyung Nam Kang2Ji Soo Jung3Chul Woo Kim4Ah Sol Kim5Department of Family MedicineBIOINFRA Life Science Inc.BIOINFRA Life Science Inc.BIOINFRA Life Science Inc.BIOINFRA Life Science Inc.Department of Family MedicineThe objective of this study was to determine whether multi-microRNA analysis using a combination of four microRNA biomarkers (miR-1246, 202, 21, and 219B) could improve the diagnostic performance of mammography in determining breast cancer risk by age group (under 50 vs. over 50) and distinguish breast cancer from benign breast diseases and other cancers (thyroid, colon, stomach, lung, liver, and cervix cancers). To verify breast cancer classification performance of the four miRNA biomarkers and whether the model providing breast cancer risk score could distinguish between benign breast disease and other cancers, the model was verified using nonlinear support vector machine (SVM) and generalized linear model (GLM) and age and four miRNA qRT-PCR analysis values (dCt) were input to these models. Breast cancer risk scores for each Breast Imaging-Reporting and Data System (BI-RADS) category in multi-microRNA analysis were analyzed to examine the correlation between breast cancer risk scores and mammography categories. We generated two models using two classification algorithms, SVM and GLM, with a combination of four miRNA biomarkers showing high performance and sensitivities of 84.5% and 82.1%, a specificity of 85%, and areas under the curve (AUCs) of 0.967 and 0.965, respectively, which showed consistent performance across all stages of breast cancer and patient ages. The results of this study showed that this multi-microRNA analysis using the four miRNA biomarkers was effective in classifying breast cancer in patients under the age of 50, which is challenging to accurately diagnose. In addition, breast cancer and benign breast diseases can be classified, showing the possibility of helping with diagnosis by mammography. Verification of the performance of the four miRNA biomarkers confirmed that multi-microRNA analysis could be used as a new breast cancer screening aid to improve the accuracy of mammography. However, many factors must be considered for clinical use. Further validation with an appropriate screening population in large clinical trials is required. This trial is registered with (KNUCH 2022-04-036).http://dx.doi.org/10.1155/2023/9117047 |
| spellingShingle | Ji-Eun Song Ji Young Jang Kyung Nam Kang Ji Soo Jung Chul Woo Kim Ah Sol Kim Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk The Breast Journal |
| title | Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk |
| title_full | Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk |
| title_fullStr | Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk |
| title_full_unstemmed | Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk |
| title_short | Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk |
| title_sort | multi microrna analysis can improve the diagnostic performance of mammography in determining breast cancer risk |
| url | http://dx.doi.org/10.1155/2023/9117047 |
| work_keys_str_mv | AT jieunsong multimicrornaanalysiscanimprovethediagnosticperformanceofmammographyindeterminingbreastcancerrisk AT jiyoungjang multimicrornaanalysiscanimprovethediagnosticperformanceofmammographyindeterminingbreastcancerrisk AT kyungnamkang multimicrornaanalysiscanimprovethediagnosticperformanceofmammographyindeterminingbreastcancerrisk AT jisoojung multimicrornaanalysiscanimprovethediagnosticperformanceofmammographyindeterminingbreastcancerrisk AT chulwookim multimicrornaanalysiscanimprovethediagnosticperformanceofmammographyindeterminingbreastcancerrisk AT ahsolkim multimicrornaanalysiscanimprovethediagnosticperformanceofmammographyindeterminingbreastcancerrisk |